No fee unless we recover compensation for your family Text size 833-4-ASBESTOS (833-427-2378) Free Case Review

The Alveolar Macrophage: Immune Derangement And Asbestos-Related Malignancy

Our plain-English summary of The Alveolar Macrophage: Immune Derangement And Asbestos-Related Malignancy, by E. Kagan (1981).

You don't need the product names or old records. No fee unless we recover compensation for your family.

Call 833-4-ASBESTOS Request a review

The study

  • Author: E. Kagan
  • Published: Seminars In Oncology 8(3):258-267, September (1981)
  • Type of article: Journal article
  • Our copy: from Johns-Manville's own medical library, J-M no. 000749. The article is still under copyright, so we describe it here rather than post it.

In plain English

This article reviewed research on how the alveolar macrophage, a lung scavenger cell, and the immune system may take part in asbestosis and asbestos-related cancers. The author described other studies alongside the author's own group's work. In one rat study, Wistar rats given UICC crocidolite by inhalation had lung macrophages with a changed surface structure. In another, complement deposits were found on lung macrophages from asbestos-exposed rats but not from unexposed rats. From experiments combining rat macrophages and lymphocytes, the group concluded there may be an asbestos-related antigen on or associated with the macrophage surface membrane. In 26 individuals with radiographic asbestosis, the group found weakened cell-mediated immunity, including skin-test anergy to DNCB in 17 and to recall antigens in 19, plus raised antibody levels. Four of the 26 (15.4%) later developed malignant neoplasms. The group also reported myeloma and chronic lymphocytic leukemia in asbestos-exposed patients. The author suggested such lymphoid cancers might result from persistent immune stimulation by asbestos. The author noted that other occupational exposures could be responsible and that direct evidence for some hypotheses was lacking.

We wrote this plain-English summary from the full article with the help of AI, and a second AI model checked each sentence against the article. It is not the authors' wording; the abstract and the article are their own account.

What the study did and found

  • Design: Review of published research, including the author's own group's animal and patient studies
  • Who was studied: Published studies of animals and asbestos-exposed people. The author's own work included Wistar rats, 26 individuals with radiographic evidence of asbestosis, and 20 workers with asbestos-related pleural thickening
  • Exposure: In the author's rat surface-structure study, intermittent inhalation of UICC crocidolite asbestos for 4 to 8 months. In the human studies, occupational asbestos exposure
  • Main results:
    • Compared with macrophages from unexposed rats, alveolar macrophages from crocidolite-exposed Wistar rats had a more intricate surface ultrastructure, spread more readily across glass, and had more surface receptors for IgG
    • In a separate study, complement components were deposited on alveolar macrophages from asbestos-exposed rats but not on those from control rats
    • From cocultures of rat macrophages and lymphocytes, the author's group concluded there may be an asbestos-related neoantigen on or associated with the macrophage surface membrane. They said the findings were consistent with T cells recognizing an asbestos-related macrophage-associated antigen (ARMAA)
    • Among the 26 individuals with asbestosis, cutaneous anergy to DNCB was found in 17 and anergy to recall antigens (Streptokinase/Streptodornase and Candida albicans) in 19
    • The same individuals with asbestosis showed significant elevations of serum IgA, IgG, IgM and IgE
    • In the 20 workers with asbestos-related pleural thickening, inhibitors of PHA-induced lymphoproliferation were detected in 25% of the sera
    • Four of the group of 26 patients with asbestosis and immune derangement (15.4%) subsequently developed malignant neoplasms
    • The author's group documented three neoplasms of B cell lineage (two myelomas and one chronic lymphocytic leukemia) in patients with asbestos exposure. They later identified seven more asbestos-associated lymphoid system cancers (four chronic lymphocytic leukemia, three myeloma)
  • The authors' conclusion: The author concluded that the asbestos-associated lymphoid cancer findings appear to be more than a chance occurrence. The author hypothesized that they could result from persistent antigenic or mitogenic stimulation of the immune system by asbestos
  • Limitations the authors state:
    • The lymphoid cancer findings could possibly be the result of toxic substances or other occupational exposures not involving asbestos
    • Direct evidence for the hypothesis that asbestos abolishes macrophage suppressor activity had not yet been shown
    • No conclusions could be drawn from the limited data on the immune status of patients with established asbestos-related cancers

Topics

Medical terms in this study, explained in our Lexicon: Alveolar Macrophage, UICC, Crocidolite, Macrophage, Neoplasm, Myeloma, Occupational Exposure.

Browse return to medical research.

How to cite it

Cite the study

E. Kagan. The Alveolar Macrophage: Immune Derangement And Asbestos-Related Malignancy. 1981.

Cite our summary

“The Alveolar Macrophage: Immune Derangement And Asbestos-Related Malignancy.” AsbestosClaims.Law Library. https://asbestosclaims.law/library/research/the-alveolar-macrophage-immune-derangement-and-asbestos-related.

ACL Doc numbers and their short links never change. See how to cite the Library.

Talk with an asbestos lawyer

Start with what you remember, and we'll take it from there.

This page is provided for general informational purposes and does not constitute legal advice. Every asbestos case turns on its own facts, exposure history, diagnosis, deadlines, available evidence, and applicable law. Reviewing this page does not create an attorney-client relationship. For advice about your specific situation, call 833-4-ASBESTOS for a free case review.